Tower Research Capital (TRC)’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14,743
| Closed | -$49K | – | 4433 |
|
|
2019
Q4 | $49K | Buy |
14,743
+9,318
| +172% | +$31K | ﹤0.01% | 1357 |
|
|
2019
Q3 | $17K | Sell |
5,425
-613
| -10% | -$1.92K | ﹤0.01% | 2597 |
|
|
2019
Q2 | $14K | Sell |
6,038
-7,953
| -57% | -$18.4K | ﹤0.01% | 2394 |
|
|
2019
Q1 | $53K | Buy |
13,991
+13,634
| +3,819% | +$51.6K | ﹤0.01% | 1745 |
|
|
2018
Q4 | $1K | Sell |
357
-486
| -58% | -$1.36K | ﹤0.01% | 3736 |
|
|
2018
Q3 | $5K | Sell |
843
-8,366
| -91% | -$49.6K | ﹤0.01% | 3158 |
|
|
2018
Q2 | $46K | Buy |
9,209
+8,425
| +1,075% | +$42.1K | ﹤0.01% | 1900 |
|
|
2018
Q1 | $4K | Buy |
+784
| New | +$4K | ﹤0.01% | 2825 |
|
|
2017
Q3 | – | Sell |
-4,872
| Closed | -$23K | – | 4442 |
|
|
2017
Q2 | $23K | Sell |
4,872
-1,346
| -22% | -$6.35K | ﹤0.01% | 1155 |
|
|
2017
Q1 | $31K | Buy |
6,218
+5,945
| +2,178% | +$29.6K | ﹤0.01% | 1014 |
|
|
2016
Q4 | $3K | Buy |
+273
| New | +$3K | ﹤0.01% | 3333 |
|
|
2016
Q3 | – | Sell |
-7,455
| Closed | -$47K | – | 4884 |
|
|
2016
Q2 | $47K | Buy |
7,455
+7,173
| +2,544% | +$45.2K | ﹤0.01% | 1601 |
|
|
2016
Q1 | $2K | Sell |
282
-1,076
| -79% | -$7.63K | ﹤0.01% | 3517 |
|
|
2015
Q4 | $11K | Sell |
1,358
-4,380
| -76% | -$35.5K | ﹤0.01% | 2054 |
|
|
2015
Q3 | $42K | Buy |
+5,738
| New | +$42K | ﹤0.01% | 1150 |
|
|
2014
Q4 | – | Sell |
-16,393
| Closed | -$89K | – | 5023 |
|
|
2014
Q3 | $89K | Buy |
+16,393
| New | +$89K | 0.01% | 1067 |
|